JP2021511327A5 - - Google Patents
Info
- Publication number
- JP2021511327A5 JP2021511327A5 JP2020539797A JP2020539797A JP2021511327A5 JP 2021511327 A5 JP2021511327 A5 JP 2021511327A5 JP 2020539797 A JP2020539797 A JP 2020539797A JP 2020539797 A JP2020539797 A JP 2020539797A JP 2021511327 A5 JP2021511327 A5 JP 2021511327A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- quinazolin
- piperidine
- fluoro
- methylphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2018051283 | 2018-01-19 | ||
| EPPCT/EP2018/051283 | 2018-01-19 | ||
| PCT/EP2019/051245 WO2019141808A1 (en) | 2018-01-19 | 2019-01-18 | C5a receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021511327A JP2021511327A (ja) | 2021-05-06 |
| JP2021511327A5 true JP2021511327A5 (enExample) | 2022-01-21 |
| JP7281470B2 JP7281470B2 (ja) | 2023-05-25 |
Family
ID=65023915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539797A Active JP7281470B2 (ja) | 2018-01-19 | 2019-01-18 | Ｃ５ａ受容体調節剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11685729B2 (enExample) |
| EP (1) | EP3740477A1 (enExample) |
| JP (1) | JP7281470B2 (enExample) |
| CN (1) | CN111683937A (enExample) |
| CA (1) | CA3087784A1 (enExample) |
| WO (1) | WO2019141808A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019137927A1 (en) | 2018-01-10 | 2019-07-18 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
| EP3740477A1 (en) | 2018-01-19 | 2020-11-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
| WO2019141803A1 (en) | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5624926A (en) | 1993-02-18 | 1997-04-29 | Kyowa Hakko Kogyo Co., Ltd. | Piperidinyl-dioxoquinazolines as adenosine reuptake inhibitors |
| PT1122253E (pt) | 1998-10-16 | 2005-11-30 | Sumitomo Pharma | Derivados de quinazolinona |
| HK1041483B (zh) | 1998-10-23 | 2004-12-24 | 霍夫曼-拉罗奇有限公司 | 雙環氮雜環 |
| JO2355B1 (en) | 2003-04-15 | 2006-12-12 | ميرك شارب اند دوم كوربوريشن | Hereditary calcitonin polypeptide receptor antagonists |
| EP1641423B1 (en) | 2003-06-26 | 2010-03-17 | Merck Sharp & Dohme Corp. | Benzodiazepine cgrp receptor antagonists |
| EP1657238A4 (en) | 2003-08-22 | 2008-12-03 | Takeda Pharmaceutical | CONDENSATE PYRIMIDINE DERIVATIVE AND ITS USE |
| US20070104740A1 (en) | 2003-12-23 | 2007-05-10 | Voorspoels Jody Firmin M | Self-microemulsifying drug delivery systems of a hiv protease inhibitor |
| US20070292421A1 (en) * | 2005-07-28 | 2007-12-20 | Feinberg Bruce B | Method for treating preeclampsia |
| WO2007028789A1 (en) | 2005-09-07 | 2007-03-15 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Quinazoline derivatives as antiviral agents |
| EP2027106A2 (en) | 2006-06-13 | 2009-02-25 | Vertex Pharmaceuticals Incorporated | Cgrp receptor antagonists |
| US7834000B2 (en) | 2006-06-13 | 2010-11-16 | Vertex Pharmaceuticals Incorporated | CGRP receptor antagonists |
| WO2008011032A1 (en) | 2006-07-17 | 2008-01-24 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| SA08280783B1 (ar) | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | مشتقات بيريدوبيريميدين كمثبطات pde4 |
| RS56332B1 (sr) * | 2010-06-24 | 2017-12-29 | Chemocentryx Inc | Antagonisti c5ar |
| US20120143725A1 (en) | 2010-12-02 | 2012-06-07 | Vinimaya Inc. | Methods and systems for influencing search and shopping decisions in electronic procurement |
| GB201106814D0 (en) * | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compounds |
| CN105705489B (zh) | 2013-09-04 | 2019-04-26 | 百时美施贵宝公司 | 用作免疫调节剂的化合物 |
| HUE038169T2 (hu) | 2013-09-06 | 2018-09-28 | Aurigene Discovery Tech Ltd | 1,2,4-Oxadiazol származékok mint immunomodulátorok |
| WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
| US10111885B2 (en) * | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
| WO2019137927A1 (en) | 2018-01-10 | 2019-07-18 | Idorsia Pharmaceuticals Ltd | 2,4,6,7-tetrahydro-pyrazolo[4,3-d]pyrimidin-5-one derivatives and related compounds as c5a receptor modulators for treating vasculitis and inflammatory diseases |
| EP3740477A1 (en) | 2018-01-19 | 2020-11-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
| WO2019141803A1 (en) | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
-
2019
- 2019-01-18 EP EP19700614.1A patent/EP3740477A1/en not_active Withdrawn
- 2019-01-18 CA CA3087784A patent/CA3087784A1/en active Pending
- 2019-01-18 JP JP2020539797A patent/JP7281470B2/ja active Active
- 2019-01-18 CN CN201980009036.7A patent/CN111683937A/zh active Pending
- 2019-01-18 WO PCT/EP2019/051245 patent/WO2019141808A1/en not_active Ceased
- 2019-01-18 US US16/963,143 patent/US11685729B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016514718A5 (enExample) | ||
| JP2021511327A5 (enExample) | ||
| RU2481333C2 (ru) | Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана | |
| JP2005531609A5 (enExample) | ||
| JP2021511324A5 (enExample) | ||
| JP2010519204A5 (enExample) | ||
| JP2018535999A5 (enExample) | ||
| IL258577A (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| RU2009147733A (ru) | Пиридилпиперидновые антагонисты рецептора орексинов | |
| JP2019518036A5 (enExample) | ||
| JP2013540119A5 (enExample) | ||
| JP2016164184A5 (enExample) | ||
| JP2013545744A5 (enExample) | ||
| JP2003503386A (ja) | １−（芳香族またはヘテロ芳香族置換）−３−（ヘテロ芳香族置換）−１，３−プロパンジオン類およびそれの使用 | |
| JP2014531465A5 (enExample) | ||
| JP2018530591A5 (enExample) | ||
| JP2017535561A5 (enExample) | ||
| JP2015164972A5 (enExample) | ||
| KR20150021036A (ko) | 피페리디닐피라졸로피리딘 유도체 | |
| JP2020532551A5 (enExample) | ||
| US20150322056A1 (en) | Factor IXa Inhibitors | |
| KR20160096612A (ko) | 5-하이드록시-4-(트리플루오로메틸)피라졸로피리딘 유도체 | |
| JP2018508553A5 (enExample) | ||
| JP2006528147A5 (enExample) | ||
| JP2020520925A5 (enExample) |